120
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization

, , , , &
Pages 1937-1947 | Published online: 14 Jun 2018

References

  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • HuiartLErnstPSuissaSCardiovascular morbidity and mortality in COPDChest200512842640264616236937
  • RuttenFHMoonsKGCramerMJRecognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic studyBMJ20053317529137916321994
  • CelliBRMacNeeWAgustiAStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
  • SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
  • PiquetJChavaillonJMDavidPMartinFBlanchonFRocheNFrench College of General Hospital Respiratory Physicians (CPHG)High-risk patients following hospitalisation for an acute exacerbation of COPDEur Respir J201342494695523349446
  • AaronSDManagement and prevention of exacerbations of COPDBMJ2014349g523725245156
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • McGarveyLPJohnMAndersonJAZvarichMWiseRATORCH Clinical Endpoint CommitteeAscertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax200762541141517311843
  • SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
  • AgustíAGNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
  • FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
  • SinDDManSFChronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalityProc Am Thorac Soc20052181116113462
  • CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
  • NeukammAMHøisethADHagveTASøysethVOmlandTHigh-sensitivity cardiac troponin T levels are increased in stable COPDHeart201399638238723315609
  • BrekkePHOmlandTHolmedalSHSmithPSøysethVTroponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbationEur Respir J200831356357018032444
  • HøisethADOmlandTHagveTABrekkePHSøysethVNT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort studyRespir Res2012139723107284
  • HøisethADNeukammAKarlssonBDOmlandTBrekkePHSøysethVElevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary diseaseThorax201166977578121653926
  • ChangCLRobinsonSCMillsGDBiochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax201166976476821474497
  • PavasiniRd’AscenzoFCampoGCardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysisInt J Cardiol201519118719325965630
  • RichJDThenappanTFreedBQTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertensionInt J Cardiol2013167366967622459397
  • WarnierMJRuttenFHNumansMEElectrocardiographic characteristics of patients with chronic obstructive pulmonary diseaseCOPD2013101627123413894
  • HoltzmanDAronowWSMellanaWMElectrocardiographic abnormalities in patients with severe versus mild or moderate chronic obstructive pulmonary disease followed in an academic outpatient pulmonary clinicAnn Noninvasive Electrocardiol2011161303221251131
  • SieviNAClarenbachCFCamenGRossiVAvan GestelAJKohlerMHigh prevalence of altered cardiac repolarization in patients with COPDBMC Pulm Med20141415524690123
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • VermeerschKGabrovskaMDeslypereGThe Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialInt J Chron Obstruct Pulmon Dis201611168769627099485
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • GoldenbergIMossAJZarebaWQT interval: how to measure it and what is “normal.”J Cardiovasc Electrophysiol200617333333616643414
  • van BuurenSGroothuis-OudshoornKMICE: multivariate imputation by chained equations in RJ Stat Softw2011453167
  • LarattaCRvan EedenSAcute exacerbation of chronic obstructive pulmonary disease: cardiovascular linksBiomed Res Int2014201452878924724085
  • Al-KhatibSMLaPointeNMKramerJMCaliffRMWhat clinicians should know about the QT IntervalJAMA2003289162120212812709470
  • SøysethVBhatnagarRHolmedahlNHAcute exacerbation of COPD is associated with fourfold elevation of cardiac troponin THeart201399212212623024006
  • VandenberkBVandaelERobynsTWhich QT correction formulae to use for QT monitoring?J Am Heart Assoc201656e00326427317349
  • RautaharjuPMZhangZMPrineasRHeissGAssessment of prolonged QT and JT intervals in ventricular conduction defectsAm J Cardiol20049381017102115081446
  • DrewBJAckermanMJFunkMAmerican Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology FoundationPrevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology FoundationCirculation201012181047106020142454